Brain and Plasma Riluzole Pharmacokinetics: Effect of Minocycline Combination
PURPOSE: amyotrophic lateral sclerosis is a fatal neurodegenerative disease characterized by the loss of motorneurons. The only drug approved is riluzole. Minocycline is an antibiotic with numerous neuroprotective properties. riluzole and minocycline were given to an animal model of ALS and had bene...
Saved in:
Main Authors: | Aline Milane (Author), Lionel Tortolano (Author), Christine Fernandez (Author), Gilbert Bensimon (Author), Vincent Meininger (Author), Robert Farinotti (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2009-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Two Efflux Proteins, ABCB1 and ABCG2 in Blood-Brain Barrier Transport of Bromocriptine in a Murine Model of MPTP-Induced Dopaminergic Degeneration
by: Sarah Vautier, et al.
Published: (2009) -
Development of a robust UPLC-MS/MS method for the quantification of riluzole in human plasma and its application in pharmacokinetics
by: Zhuo Sun, et al.
Published: (2023) -
Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain
by: Maria Inês Teixeira, et al.
Published: (2022) -
N-Succinylaspartic-Acid-Conjugated Riluzole Is a Safe and Potent Colon-Targeted Prodrug of Riluzole against DNBS-Induced Rat Colitis
by: Jaejeong Kim, et al.
Published: (2023) -
Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins
by: Tatyana Volkova, et al.
Published: (2024)